Oncology

These insightful articles highlight the modern diagnostic and treatment measures for feline and canine MCTs.

The program will be a part of the NCI’s “comprehensive” Cancer Center designation renewal.

Funding will go towards a Canada-based researcher studying early detection and/or prevention of canine cancer to achieve better outcomes for dogs impacted by this disease.

In a recent interview with dvm360®, Dr Ettinger outlines various tips and tricks for diagnosing and treating MCTs in dogs.

Sue Ettinger, DVM, DACVIM (Oncology) discussed innovations in canine cancer treatment during a keynote address at the Atlantic Coast Veterinary Conference.

A novel immunotherapy for dogs with osteosarcoma is discussed.

Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses reasons why some pet owners decline to have their dogs provided with treatment for lymphoma and how veterinarians can help clients address these challenges.

Anivive Lifesciences Inc Founder, CEO and Chairman Dylan Balsz discussed the company’s mission and how it is working to serve unmet needs in veterinary health.

In an interview with dvm360®, Sue Ettinger, DVM, DACVIM (Oncology)—Dr Sue Cancer Vet—offers insight about what to tell pet owners when their dog has been diagnosed with lymphoma.

Anivive Lifesciences' Chief Commerical Officer Chad Todd, DVM, offers insight on Laverdia-CA1, the first conditionally approved oral treatment for canine lymphoma.

Virbac’s tigilanol tiglate injections (Stelfonta) has been approved by the FDA for treatment of the most common type of skin cancer in dogs.

During a session at an AVMA Virtual Convention, a veterinary cancer specialist discusses key facts about the disease to help clients make the best decision for their pet.

OncoK9 offers new cancer-detection capabilities enabling veterinarians to provide the highest quality of care to their canine patients.

A survey from the Pet CancerCare Alliance provides insight into pet owners' attitudes about cancer and how likely they are to pursue treatment. (Sponsored by VCA)

From the clinical examination to procedure and treatment methods to the outcome, discover this beagle’s experience undergoing radiation therapy for an MCT.

The association’s Oncology Working Group aims to establish clear guidelines with the goal of enhancing the quality of care provided to patients and education offered to pet owners.

Expand your practical knowledge with these articles highlighting the latest in veterinary cancer diagnosis and treatment.

Considerations for the use of echocardiography to evaluate suspected tumors located in the heart.

Check out this week's news.

A sneak peek at this week’s headlines.

Laverdia-CA1 provides an additional treatment option for dogs suffering from this devastating illness.

A renowned veterinary oncologist outlines the current knowledge about this cancer of the blood vessel walls, from presentation to prognosis.

Cancer diagnostics and therapeutics continue to evolve, potentially lessening the associated invasiveness, duration, and cost.

These 1-hour events will address a wide array of veterinary topics including owner compliance, pet insurance, oncology, and telemedicine.

The simple blood test employs technology that looks for very early nucleosomic markers of cancer in dogs.

A little sneak peek at this week’ headlines.

When veterinarians and veterinary teams work as a cohesive team, workflow is smoother and patient and client care improves.

Early detection of disease is key to maximizing an older dog’s quality of life. Teaching owners about common ailments can help these ptients get appropriate treatment sooner rather than later.